LifeMD, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from LifeMD, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $2 per $100 of sales comes from others' credit, against $8 from others' credit three years earlier. Less money tied up than 91% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 12.9 times by its yearly operating cash. Higher than 87% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
1.3×Over the last 3 years its own operating cash covered its investment spending (capex) 1.3 times.
Higher than 70% of Healthcare companies in United States.
Cash Locked Ratio
−$2Money owed to suppliers is larger than money owed by customers plus stock: $2 per $100 of sales comes from others' credit, against $8 from others' credit three years earlier.
Less money tied up than 91% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$80Sales grew 63% in 3 years; of every extra $100 of sales, $80 became extra profit.
Higher than 77% of Healthcare companies in United States.
Asset Productivity Ratio
+63% / +174%In 3 years sales changed by +63% while total assets changed by +174%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
12.9×Debt due within a year is covered 12.9 times by its yearly operating cash.
Higher than 87% of Healthcare companies in United States.
Cash Cushion Ratio
+29%Cash, after subtracting all debt, equals 29% of its market value (net cash).
Higher than 68% of Healthcare companies in United States.
Tangible Assets Ratio
85%Of every $100 the company owns, $85 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 55% of Healthcare companies in United States.
Tangible Net Worth Ratio
53%Of every $100 of net worth, $53 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 51% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
LifeMD, Inc. made a loss over the last year. LifeMD, Inc. owes $0.87 for every $1 it owns. LifeMD, Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossLifeMD, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
13.14The share price is 13.14 times LifeMD, Inc.'s book value per share, higher than 89% of Healthcare companies in United States.
Market cap
$105 MThe total market value of all of LifeMD, Inc.'s shares at today's price (share price × number of shares), smaller than 65% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$8 MWhat LifeMD, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.17Net worth divided by the number of shares. The share price of $2.17 is 13.1 times this, which is the P/B above.
Return on equity (ROE)
-515.9%LifeMD, Inc. lost 515.9% of its shareholders' money over the last year, lower than 93% of Healthcare companies in United States.
Owes vs Owns
0.87×LifeMD, Inc. owes $0.87 for every $1 it owns (high), higher than 81% of Healthcare companies in United States.
Dividend yield
NoneLifeMD, Inc. does not currently pay a dividend.
Revenue growth
+25%Revenue rose 25% in the year to Dec 2025, and grew 18% a year on average over 3 years.
Profit growth
Back to profitLifeMD, Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Profit margin
7.4%LifeMD, Inc. keeps $7 of every $100 of revenue as net profit.
Cash quality
0.6×Cash from LifeMD, Inc.'s business was 0.6× its reported profit in the year to Dec 2025 — less cash came in than the profit reported.
Interest cover
Not coveredLifeMD, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashLifeMD, Inc. held $30 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For LifeMD, Inc.: $105 M ÷ $8 M (30 Jun 2026) = 13.1.
What is LifeMD, Inc.'s return on equity?
LifeMD, Inc. lost 515.9% of its shareholders' money over the last year, lower than 93% of Healthcare companies in United States.
How much does LifeMD, Inc. owe compared with what it owns?
LifeMD, Inc. owes $0.87 for every $1 it owns (high), higher than 81% of Healthcare companies in United States.
Does LifeMD, Inc. pay a dividend?
No. LifeMD, Inc. does not currently pay a dividend.
Is LifeMD, Inc.'s revenue growing?
Revenue rose 25% in the year to Dec 2025, and grew 18% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.